This grant opportunity, PAR-26-064, is for Specialized Programs of Research Excellence (SPOREs) in human cancers for the years 2027-2029. It requires a clinical trial and falls under CFDA 93.395.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.